Indonesia Digest: Kalbe to invest $51m in new plant; Artajasa eyes $3.2m via IPO

Indonesia Digest: Kalbe to invest $51m in new plant; Artajasa eyes $3.2m via IPO

Indonesia’s pharmaceutical firm Kalbe Farme has invested $35 million in the construction of a new factory with another $16 million to be spent for operational support, while electronic transaction service provider Artajasa Pembayaran Elektronis has said that it will offer 437,505,800 new shares priced at Rp 100 apiece in its IPO.

Kalbe Farma earmarks $51m investment for new Jakarta plant

Indonesia’s largest pharmaceutical company Kalbe Farma announced that it will invest a total of about $51 million to launch its first biological drug factory as it aims to gain higher margins from its products.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter